Zachary Bergson

Zachary Bergson

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Schizophrenia Research
Verified
Journal Article
Closed access
ZBZachary Bergson
Zachary Bergson
AAAnthony O. Ahmed
Anthony O. Ahmed
JBJewel Bell
Jewel Bell
PBPamela Butler
Pamela Butler
JGJames Gordon
James Gordon
VZVance Zemon
Vance Zemon

29 March 2023 in Psychology of Music
Verified
Journal Article
Closed access
ZBZachary Bergson
Zachary Bergson
CNChayim Newman
Chayim Newman
RGRyan P George
Ryan P George
TBTim Beitz
Tim Beitz
VZVance Zemon
Vance Zemon
This study aimed to elucidate factors related to suicidality in a high-stress population—music industry touring professionals. It also examined whether trait mindfulness plays a moderating role in relations among these factors and suicidality. Touring professionals ( N = 1,154) responded to an online questionnaire that included the Center for Epidemiological Studies Depression Scale–Revised (CES-D), Perceived Stress Scale (PSS), Suicide Behavior Questionnaire–Revised (SBQ-R), and the Mindful Attention Awareness Scale (MAAS). Mediation and moderated-mediation analyses were conducted on data from completed instruments ( n = 550) with PSS as the antecedent, CES-D as the mediator, MAAS as the moderator, and SBQ-R as the outcome. The indirect effect of stress through depressive symptoms on suicidality was significant. The moderation of this indirect effect by mindfulness also reached significance, with greater mindfulness scores associated with an attenuation of the impact of stress on suicidality through depressive symptoms. Mindfulness was a moderator of stress on depressive symptoms and suicidality. Mindfulness-based interventions for populations under high stress, such as touring professionals, may be an important topic for future research.

8 June 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ZBZachary Bergson
Zachary Bergson
SVSarah G. Vassall
Sarah G. Vassall
AWAdam Wright
Adam Wright
AMAllison B. McCoy
Allison B. McCoy
KSKatherine M. Schafer
Katherine M. Schafer
JSJulia M. Sheffield
Julia M. Sheffield
Background: Concerns about “AI psychosis” have swirled in the media since ChatGPT’s release, but few systematic analyses exist. We therefore conducted an electronic health record (EHR) analysis to identify the frequency, clinical characteristics, and quality of AI interactions in patients experiencing psychosis treated in a medical center. Methods: AI keywords (e.g., ChatGPT, AI) were used to search Vanderbilt University Medical Center’s EHR from 12/1/2022-4/1/2026. Records were discarded if they were not AI-related or if the primary diagnosis did not include psychosis. Three raters read notes to determine if a patient was experiencing AI psychosis and classified the interactions using 4 a-priori categories (Catalyst, Amplifier, Co-Author, Object) formulated to explain how AI-related negative outcomes emerge. Findings: 73 patients met our criteria. 28 patients were rated as experiencing AI psychosis, 17 had neutral interactions, and 28 expressed delusional content related to AI without documented evidence of conversational AI use. ChatGPT was the matching keyword for 53.6% patients experiencing AI psychosis. The majority of AI psychosis cases were documented after ChatGPT’s “4o” model was released in May 2024. Notably, the AI Psychosis group had significantly more patients experiencing a first psychotic episode (60.7%) compared to the other two groups. Amplifier was the most common (64.3%) qualitative rating in the AI Psychosis group. Interpretation: “AI psychosis” is an infrequent but real phenomenon observed in clinical practice. Most affected patients were experiencing their first psychotic episode and presented with AI psychosis following the release of the more sycophantic GPT-4o. Among the affected patients, AI most often exacerbated an existing condition by reinforcing distorted ideas.

26 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ZBZachary Bergson
Zachary Bergson
MRMaxwell J. Roeske
Maxwell J. Roeske
BRBaxter P. Rogers
Baxter P. Rogers
AHAnna S. Huang
Anna S. Huang
VFVictoria Fox
Victoria Fox
NWNeil D. Woodward
Neil D. Woodward
The massa intermedia (MI) is a midline structure connecting the left and right thalamus that typically develops during the 2 nd trimester of pregnancy. Missing and smaller MI has been linked to neurodevelopmental disorders, including schizophrenia (SZ), and subtle deficits in cognition. However, findings are inconsistent and the association between MI and other anatomical variants linked to atypical brain development in SZ, including incomplete hippocampal inversion (IHI), is unclear. Presence/absence and morphology of the MI were ascertained on structural T1-weighted MRI images obtained at 3T in SZ ( n = 223) and healthy individuals ( n = 194) and compared between groups. Associations between MI morphology, cognitive function, and incomplete hippocampal inversion (IHI) were assessed. Prevalence of missing MI was 1.7% and did not differ between groups. MI was significantly smaller in SZ ( p <.001). However, follow-up analyses revealed that smaller MI size in SZ was due to a significant Diagnosis x Age interaction characterized by a stronger negative age effect in SZ. IHI was significantly more common in individuals with missing MI. Neurocognition was not correlated with MI size when controlling for age and diagnosis. Stronger effects of age on MI size in SZ suggests that abnormal MI size measured in adulthood may not be a reliable static indicator of atypical neurodevelopment, but may reflect disease progression or accelerated aging. Missing MI was rare in our sample. Conversely, missing MI is associated with IHI suggesting a shared neurodevelopmental disruption in the 2 nd trimester.